PubMed Health⌕ Search

Biomedical subjects

Pierre Vidailhet

Publications and source records attributed to Pierre Vidailhet.

4 recordsLinked to original sources

Evidence for impaired mnemonic strategy use among patients with schizophrenia using the part-list cuing paradigm.

PURPOSE: Strategic and mnemonic abilities of person with schizophrenia (SCZ) were studied using a part-list cuing (PLC) task. In this task, presentation of retrieval cues in the form of a subset of studied words typically impairs recall of the remaining items. This impairment is thought to reflect a disruption of participants' natural retrieval strategies. METHODS: Participants with SCZ and healthy controls (ns = 28) studied word lists with three different levels of semantic organization: (a) unrelated, (b) categorized, but presented in a random order, and (c) presented by category. For each type of list, participants recalled words under both free-recall and PLC conditions. RESULTS: Consistent with SCZ-related impairment of strategic retrieval processes, the SCZ group was less disrupted by PLC interference than controls in the unrelated-list condition. Comparison of free recall across lists also indicated a consistent deficit in SCZ despite varying levels of difficulty and retrieval contexts. Nonetheless, the SCZ group demonstrated parallel improvement to the healthy group with increasing list organization. CONCLUSIONS: These results provide evidence of deficient retrieval processes in SCZ in a context placing maximal requirements for utilization of self-initiated, effortful, mnemonic strategies. Unlike most extant results demonstrating mnemonic impairment in persons with SCZ, the present results cannot be accounted for by task difficulty; SCZ participants' recall was less disrupted by PLC than was that of healthy participants. Results also demonstrated that SCZ participants could benefit, in terms of recall and strategy use, from list organization when this structure was explicitly provided at test.

Adult↗

Dissociation between perceptual processing and priming in long-term lorazepam users.

Acute effects of lorazepam on visual information processing, perceptual priming and explicit memory are well established. However, visual processing and perceptual priming have rarely been explored in long-term lorazepam users. By exploring these functions it was possible to test the hypothesis that difficulty in processing visual information may lead to deficiencies in perceptual priming. Using a simple blind procedure, we tested explicit memory, perceptual priming and visual perception in 15 long-term lorazepam users and 15 control subjects individually matched according to sex, age and education level. Explicit memory, perceptual priming, and the identification of fragmented pictures were found to be preserved in long-term lorazepam users, contrary to what is usually observed after an acute drug intake. The processing of visual contour, on the other hand, was still significantly impaired. These results suggest that the effects observed on low-level visual perception are independent of the acute deleterious effects of lorazepam on perceptual priming. A comparison of perceptual priming in subjects with low- vs. high-level identification of new fragmented pictures further suggests that the ability to identify fragmented pictures has no influence on priming. Despite the fact that they were treated with relatively low doses and far from peak plasma concentration, it is noteworthy that in long-term users memory was preserved.

Adult↗

Recurrence of post-traumatic stress disorder and antiretrovirals.

This is the first report of a patient who experienced a recurrence of PTSD repeatedly after 2 attempts to initiate antiretrovirals including efavirenz for HIV infection. After recurrence of PTSD, the patient showed an important decrease in viral load and a higher CD4 level despite a bad compliance to antiretrovirals.

Adult↗

"Dopamine-dependent" side effects of selective serotonin reuptake inhibitors: a clinical review.

OBJECTIVE: Neurophysiologic findings indicate an inhibition of dopaminergic neurotransmission by selective serotonin reuptake inhibitors (SSRIs). This article highlights the relationships between changes in dopaminergic neurotrans-mission induced by SSRIs and the occurrence of certain side effects such as hyperprolactinemia, extrapyramidal symptoms, sexual and cognitive dysfunction, galactorrhea, mammary hypertrophy, and, more rarely, gynecomastia. DATA SOURCES AND SELECTION: A systematic search of the literature in English, French, and German from 1980 to 2004 was performed in MEDLINE, EMBASE, and the Cochrane Library using the keywords SSRI, dopamine, serotonin, side effects, antidepressants, citalopram, escitalopram, sertraline, paroxetine, fluoxetine, fluvoxamine, and nefazodone. References cited in all trials were searched iteratively to identify missing studies. All studies concerning inhibition of dopaminergic neurotransmission by SSRIs and SSRI-related side effects were considered. We retained 62 significant articles debating the subject. DATA EXTRACTION AND SYNTHESIS: We critically reviewed the studies, depending on the methodologies (case reports, clinical reports, randomized studies), and assessed the pertinence of "dopamine-dependent" SSRI-related side effects. The analytic review of these articles suggests that some specific SSRI-related side effects be classified as dopamine-dependent. CONCLUSIONS: At a clinical level, it could be useful to underline dopamine-dependent characteristics of some SSRI-related side effects. This approach would allow clinicians the opportunity to search other dopamine-dependent side effects systematically. At a pharmacologic level, this approach could stimulate the development of molecules with a "corrective" function on dopamine-dependent side effects of SSRIs by facilitating dopaminergic neurotransmission.

Basal Ganglia Diseases↗